Singapore
Leaders shared their insights on the rise of Middle East capital and new PE strategies in China.
1
Climate sector ‘capital guzzler’ but return potential emerging: BII
2
Indonesia's Green Rebel Foods bags $10.5m from existing backers
3
Novo Holdings acquires minority stake in India's Surya Hospitals
4
Indian AI startup Emergent raises $70m in round led by Softbank, Khosla Ventures
5
Walmart-backed payments firm PhonePe gets nod for Indian IPO: report
More Stories
Indonesian medical devices maker Oneject draws investor interest for minority stake
Vietnam-based fashion retailer Hapas looks to raise $15m
Indonesia AI startup SPUN raises $1.8m led by Genesia Ventures
GudangAda revenue shrinks in 2024, bets on beauty retail after FMCG stumble
Healthcare provider HMI posts double-digit profit, revenue growth in 2025
There are challenges like the lack of experienced tech investors.
Indonesia
E-commerce, edtech, and healthtech have seen a marked uptick in adoption after COVID-19.
VCs in the region must educate Western investors on Southeast Asia’s potential.
“Big Tech needs to be regulated to support, hold, and groom homegrown startups.”
The US-China trade war has had a palpable impact on investing.
A global footprint helps in hedging risks.
India’s tightening of investment regulations for neighbouring countries opens avenues for SE Asian VCs.
Mock meat, biotech, and EVs are among the sunrise sectors in SE Asia.
“In the next five years, there’ll be opportunities to invest $10-14m in the consumer sector.”
